Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from a physician concerning a patient who was vaccinated with a third dose of Rotateq. Subsequently, 4 weeks after the third dose, the patient developed intussusception. It was noted that the patient''s chart was not at the office so no further data was available at the time of the report. Upon internal review, the patient''s intussusception was considered to be an other important medical event. Additional information has been requested.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166